Rheinmetall's Contract Pipeline Keeps Delivering as the Stock Tests Oversold Territory

Rheinmetall shares fell 2.1% Friday to EUR 993, about 51% below their 52-week high, as sector-wide defence weakness outweighed a strong order book.

Rheinmetall shares finished Friday at EUR 993.00, down 2.1% on the day, capping a bruising stretch that has left the German defence contractor roughly 51% below its 52-week peak of EUR 2,007.00 set on 3 October 2025. The decline has been relentless across timeframes: 4.0% over the past week, 15% across 30 days, and 36% since the start of the year. Technical readings now place the stock's RSI at 33.8, edging toward oversold territory, while the price sits about 9.2% beneath its 50-day moving average.

No single company-specific event explains the latest leg down. According to media coverage, the stock has been caught in a broad pullback across European defence names, a sector-wide drag that has weighed on sentiment regardless of individual fundamentals.

JPMorgan's Warning Adds to the Pressure

One factor that sharpened the recent selling was a note from JPMorgan, which on Wednesday placed Rheinmetall on its "Negative Catalyst Watch" — a flag for potential near-term headwinds — while keeping its rating at "Neutral." The timing coincided with the wider softness in European defence stocks, likely amplifying the downward move.

Other themes circulating in press reports may also have contributed. Among them: a reported cut to the 2026 revenue forecast tied to the loss of the F126 frigate project, which went to TKMS rather than Rheinmetall. There was also speculation that Rheinmetall could trim munitions spending for 2027, even as German defence budgets are expected to keep rising. A sharp drop on 1 September drew attention at the time without any clearly identifiable primary trigger.

An earlier buy recommendation from Deutsche Bank Research, with a price target of EUR 1,800 confirmed on 1 September, dates from a period when the shares traded far above current levels and no longer reflects the present analyst landscape.

Order Book Tells a Different Story

Against the market's gloom, the operating side keeps producing. American Rheinmetall landed a USD 7.28 million order from the U.S. Marine Corps on 10 September for twelve Mission Master vehicles complete with amphibious equipment and accessories, with delivery scheduled between late 2026 and late 2028. Rheinmetall Canada had already announced a contract on 4 September for replacement components for mobile air-start units for the U.S. Navy, awarded through the Canadian Commercial Corporation and valued in the low single-digit millions.

Earlier in September, Kongsberg Defence & Aerospace placed an order worth roughly USD 710,000 for American Rheinmetall to manufacture components for MCT-30 turrets used in the ACV-30 program for the U.S. Marines, with production in Michigan and delivery in 2026 and 2027. Rheinmetall also confirmed a strategic partnership on Tuesday with MAN Truck & Bus and the WB Group covering military vehicle solutions for European armed forces. American Rheinmetall has additionally been mentioned in connection with a possible large U.S. military order for infantry fighting vehicles.

The financials back up the order momentum. In its 2026 half-year report, Rheinmetall posted revenue of EUR 5.2 billion, an operating result of EUR 786 million, and an operating margin of 15%. Its order backlog stood at EUR 80.5 billion. For the full year, management guided toward revenue of EUR 13.7 to 14.2 billion and an operating margin of roughly 19%.

A Brief Rally That Faded

The market has been unmoved by that story. A mid-week rebound attempt on 8 September briefly pushed the shares more than 3% higher on an optimistic analyst call, but with no fresh company news behind it, the gain evaporated within days. Rheinmetall spent the week courting investors directly — a meeting with Bernstein in London and the Jefferies Industrials Conference in New York on 9 September, followed by Gabelli Funds' 32nd Annual A&D Symposium a day later.

Whether those engagements can restore confidence is an open question. The order pipeline remains healthy and the guidance intact, yet the price action of recent weeks makes clear that macro and sector-wide concerns are currently drowning out company-specific news. For shareholders, the gap between the backlog and the share price remains the defining tension.